Meta-analysis of FGFR gene amplification status and OS in a variety of cancers was performed; 1345 patients in 6 studies for FGFR1 amplification and 1344 patients in 3 studies for FGFR2 amplification were included. This evidence concerns the gene FGFR2 and cancer.